DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. for the RIO-North America Study Group.
Effect of Rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: A randomized conrolled Trial.
JAMA 2006; 295: 761-775
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.